Luitpold Pharmaceuticals, Inc.

Norristown, Pennsylvania 19403

0 studies enrolling now · 10 studies all time

What they study most

Anemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Impaired Renal Function, Iron Deficiency Anemia, Iron Deficiency Anemia (IDA), Malignant Melanoma, Myelodysplastic Syndrome, Myelofibrosis, Pain

Studies at this site

• Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma — Stopped early
• Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza — Completed
• Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) — Completed
• Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease — Completed
• Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function — Completed
• Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding — Completed
• Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women — Completed
• Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia — Completed
• Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum) — Withdrawn before enrolling
• Pharmacokinetics, Safety, and Efficacy of SPRIX in 12 to 17 Year Old Patients vs. Adult Patients Undergoing Open Surgical Procedures — Completed